483 Novartis Pharma Stein AG Sep 2018

483 Novartis Pharma Stein AG Sep 2018

Wayne Seifert FDA$119.00 - Available Now

FDA investigators audited the Novartis Pharma Stein AG - Stein AG, Switzerland facility and issued inspectional observations (via FDA 483) on 21 Sep 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 21 Sep 2018
  • Location: Stein AG, Switzerland
  • FEI: 3002653483
Add To Cart